SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001016504-12-000017
Filing Date
2012-06-29
Accepted
2012-06-29 16:16:37
Documents
19
Period of Report
2012-06-27
Filing Date Changed
2012-06-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 inb8k_20120628.htm 8-K 52841
2 exhibit10_1.htm EX-10.1 1011603
3 exhibit10_2.htm EX-10.2 36521
4 exhibit10_3.htm EX-10.3 35823
5 exhibit10_4.htm EX-10.4 38749
6 exhibit10_5.htm EX-10.5 39960
7 exhibit10_6.htm EX-10.6 46849
8 exhibit10_7.htm EX-10.7 58609
9 exhibit10_8.htm EX-10.8 143321
10 ex10_8.gif GRAPHIC 1312
11 exhibit10_9.htm EX-10.9 128491
12 exhibit10_10.htm EX-10.10 656322
13 exhibit10_11.htm EX-10.11 249655
14 exhibit10_12.htm EX-10.12 134817
15 exhibit10_14.htm EX-10.14 55843
16 exhibit10_13.htm EX-10.13 64407
17 exhibit10_15.htm EX-10.15 73867
18 exhibit99_1.htm EX-99.1 11669
19 inblogo1.jpg GRAPHIC 14702
  Complete submission text file 0001016504-12-000017.txt   2863096
Mailing Address 201 ROUTE 22 HILLSIDE NJ 07205
Business Address 201 ROUTE 22 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

IRS No.: 222407475 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-31668 | Film No.: 12936253
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1